Navigation Links
Beat menopausal symptoms with low-dose estrogen

Results of two new studies suggest that low-dose estrogen therapy should be considered first line treatment for women experiencing menopausal hot flushes and bleeding. The June issue of Fertility and Sterility says low-dose estrogen therapy is as effective as high-dose estrogen in treating menopausal symptoms. Low-doses are actually are more effective in stopping the irregular bleeding.

Dr. Wulf H. Utian, a professor at Case Western Reserve University and president of The North American Menopasue Society in Cleveland, Ohio, headed the research. He noted that side effects such as breast tenderness, irregular bleeding and negative mood, as well as the fear of breast cancer risk, cause many women to discontinue Hormone Replacement Therapy (HRT).//

While HRT can relive some of the painful and debilitating symptoms of menopause, reduce the risk of heart disease and protect aginst endometrial cancer, it may also raise a woman's risk of breast cancer, particularly at higher doses. On the contrary, the advantages of low-dose therapy is that a patient can get the same effect as with higher doses and also reduce the side effects.

A second study of the same group of women found that lower doses of hormones stopped irregular bleeding more effectively than did higher dose HRT over one year, particularly in the earlier stages of therapy.


'"/>




Page: 1

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with CAD
2. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
3. Exercise The Ideal Solution For Postmenopausal Women
4. Enlarged waistline may predict atherogenesis for postmenopausal women
5. Research explains why postmenopausal women accumulate abdominal fat.
6. Insight for Hot Flashes In Postmenopausal Women
7. New Insight In Periodontal Disease In Postmenopausal Women
8. Low bone mass in Postmenopausal Women
9. Consumption of Soy May Reduce Risk of Fracture in Postmenopausal Women
10. Testosterone Therapy can improve sexual function in postmenopausal women
11. Perimenopausal Hormone Therapy Fights Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... ... August 3rd article on Reuters covers a new University of Michigan study on ... of the American Medical Association). The study found that a lower percentage of patients with ... to patients with lower BMIs. At present, weight loss patients must have a BMI of ...
(Date:8/16/2017)... Va. (PRWEB) , ... August 16, 2017 , ... ... America (BIAA) is collaborating with a New England student to educate the public ... to acclaim in 2016 for launching the first-ever National Concussion Awareness Day. , ...
(Date:8/16/2017)... ... , ... Maury Regional Health has announced a large-scale adoption of AccuVein vein ... Maury Regional Medical Center is making vein visualization part of their standard of care. ... more importantly, helps our staff members locate a vein that will provide good access ...
(Date:8/16/2017)... ... August 16, 2017 , ... With a new PD diagnosis every ... cure. , The grants are awarded through a competitive application process and reviewed ... array of backgrounds and expertise in all areas relevant to PD research. The ...
(Date:8/16/2017)... Sacramento, CA (PRWEB) , ... August 16, 2017 ... ... ($10.99, paperback, 9781498499613; $5.99, eBook, 9781498499620    ) shares that during the time of a ... as reminding Strawn of God's love, and all the many ways God shows ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has been named one of ... by Crain,s Detroit Business . The annual Crain,s ... revenue growth. This year,s edition measures growth from 2013 to ... complete list, visit crainsdetroit.com/awards/fast_50/2017 .  "Being ... Phil Hagerman , CEO and chairman of Diplomat. "We,ve ...
(Date:7/27/2017)... 27, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... June 30, 2017.  The Company reported second quarter net ... the prior year period, and an increase of 2.1% ... points of contribution from the LDR Holding Corporation acquisition, ... quarter of 2016, or 0.3% on a constant currency ...
(Date:7/26/2017)... The Galien Foundation announced today the ... Award Nominees. Counted among the global health innovation ... biomedical and technology product achievement that improves the human condition. ... candidate must be U.S. Food and Drug Administration (FDA) approved ... potential to impact human health. Sales data are not considered ...
Breaking Medicine Technology: